Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

PHARMACIE DU MAUREGARD : revenue, balance sheet and financial ratios

PHARMACIE DU MAUREGARD is a French company founded 42 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in EPINAY-SUR-ORGE (91360), this company of category PME shows in 2016 a revenue of 1.3 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-02

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - PHARMACIE DU MAUREGARD (SIREN 329583066)
Indicator 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016
Revenue N/C N/C N/C N/C N/C N/C N/C N/C N/C 1 275 492 €
Net income 13 275 € 15 275 € 44 533 € 136 763 € 49 011 € 60 725 € 95 598 € 110 634 € 96 144 € 58 879 €
EBITDA N/C N/C N/C N/C N/C N/C N/C N/C N/C 49 473 €
Net margin N/C N/C N/C N/C N/C N/C N/C N/C N/C 4.6%

Revenue and income statement

En 2025, PHARMACIE DU MAUREGARD genera un resultado neto positivo de 13 k€. Evolución 2016-2025: 59 k€ -> 13 k€.

Net income (2025) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

13 275 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

El ratio de endeudamiento (= Deuda financiera / Fondos propios x 100) se sitúa en 104%. El nivel de deuda es alto: el margen de negociación con los bancos se reduce. La autonomía financiera (= Fondos propios / Total activo x 100) alcanza el 38%. El equilibrio entre fondos propios y deuda es satisfactorio.

Debt ratio (2025) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

103.983%

Financial autonomy (2025) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

37.75%

Asset age ratio (2025) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

13.7%

Solvency indicators evolution
PHARMACIE DU MAUREGARD

Sector positioning

Ratio de endeudamiento
103.98 2025
2023
2024
2025
Q1: 13.7
Med: 49.79
Q3: 129.09
Average

En 2025, el ratio de endeudamiento de PHARMACIE DU MAUREGARD (103.98) se sitúa por encima de la mediana del sector. Este ratio mide el peso de la deuda en relación con el patrimonio. Un esfuerzo de reducción podría mejorar la solidez financiera.

Autonomía financiera
37.75% 2025
2023
2024
2025
Q1: 33.42%
Med: 53.72%
Q3: 72.08%
Average

En 2025, el autonomía financiera de PHARMACIE DU MAUREGARD (37.8%) se sitúa por debajo de la mediana del sector. Este ratio representa la parte del patrimonio en la financiación total. Una mejora fortalecería la posición competitiva.

Liquidity ratios

El ratio de liquidez se sitúa en 198.93. La empresa tiene 2€ de activos líquidos por cada 1€ de deuda a corto plazo.

Liquidity ratio (2025) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

198.929

Liquidity indicators evolution
PHARMACIE DU MAUREGARD

Sector positioning

Ratio de liquidez
198.93 2025
2023
2024
2025
Q1: 131.03
Med: 182.25
Q3: 258.64
Bueno

En 2025, el ratio de liquidez de PHARMACIE DU MAUREGARD (198.93) se sitúa por encima de la mediana del sector. Este ratio mide la capacidad de cubrir deuda a corto plazo con activos corrientes. Esta posición cómoda ofrece un margen de seguridad apreciable.

Working capital requirement (WCR) and payment terms

El fondo de maniobra operativo (FM) mide el desfase temporal de tesorería.

Operating WCR (2025) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

0 €

Customer credit (2025) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

0 j

Supplier credit (2025) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

0 j

Inventory turnover (2025) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR and payment terms evolution
PHARMACIE DU MAUREGARD

Positioning of PHARMACIE DU MAUREGARD in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Valuation estimate

Based on 277 transactions of similar company sales in 2025, the value of PHARMACIE DU MAUREGARD is estimated at 210 874 € (range 143 100€ - 330 891€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2025
277 transactions
143k€ 210k€ 330k€
210 874 € Range: 143 100€ - 330 891€
NAF 5 année 2025

Valuation method used

Net Income Multiple
13 275 € × 15.9x = 210 875 €
Range: 143 101€ - 330 892€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare PHARMACIE DU MAUREGARD with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about PHARMACIE DU MAUREGARD

What is the revenue of PHARMACIE DU MAUREGARD ?

The revenue of PHARMACIE DU MAUREGARD in 2016 is 1.3 M€.

Is PHARMACIE DU MAUREGARD profitable?

Yes, PHARMACIE DU MAUREGARD generated a net profit of 13 k€ in 2025.

Where is the headquarters of PHARMACIE DU MAUREGARD ?

The headquarters of PHARMACIE DU MAUREGARD is located in EPINAY-SUR-ORGE (91360), in the department Essonne.

Where to find the tax return of PHARMACIE DU MAUREGARD ?

The tax return of PHARMACIE DU MAUREGARD is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does PHARMACIE DU MAUREGARD operate?

PHARMACIE DU MAUREGARD operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.